In recent years, with the market's growing demand for biomedicine and the country's increasing emphasis on the development of bio-innovative medicines, the scale of China's biopharmaceutical industry is growing at a faster rate and has become a national strategic emerging industry. According to the "2016-2020 China Pharmaceutical Industry Investment Strategy Research and Consulting Report" issued by the China Commercial Industry Research Institute, the size of China's biopharmaceutical market will reach 853.2 billion yuan, with a compound growth rate of 18.1%.
853.2 billion yuan, biopharmaceutical industry has become a hot spot
In the past five years, the country's major scientific and technological programs have invested about 60 billion yuan in the field of life sciences. In this environment, China's biotechnology has not only developed rapidly, but its industrial scale has also grown. In 2018, the market size of China's biopharmaceutical industry has exceeded 350 billion yuan, and a total of nine independent Class 1 new drugs have been approved for listing. This is a year in which China has approved a record number of Class 1 new drugs. As of November 2018, the main business income of pharmaceutical industry enterprises above a certain size in China was nearly 2.6 trillion yuan, an increase of 12.7% year-on-year, and a profit of 336.45 billion yuan. It can be seen that the future of the biopharmaceutical market is promising and the growth space is huge *.
In fact, the research and development of biotechnology drugs in China started relatively late, and it was not until the early years that the recombination technology began to be applied to medicine. However, in recent years, a series of high-frequency policies and market environment of the country have promoted multiple benefits. The pharmaceutical industry is embracing huge development opportunities. However, opportunities often coexist with challenges. We must know that the biopharmaceutical industry is an investment field with large investments, slow results and high risks. How to improve production efficiency, reduce production costs, ensure drug safety, and shorten the time to market for new products are the focus of enterprises. Concerns. So how do enterprises act in the face of huge market opportunities and challenges?
It is understood that on August 26-28, 2020, the eighth Shanghai International Biofermentation Products and Technology Equipment Exhibition (hereinafter referred to as "Shanghai Biofermentation" Exhibition ") will be held at the Shanghai New International Expo Center, when many people of insight will come together to guide the development of the biopharmaceutical industry.
2020 Shanghai Fermentation Exhibition, focusing on various "new" in the biopharmaceutical industry
With the strong support of the policy, the industry said that in the future, it may be a good time for the innovation and development of China's biological and pharmaceutical industries, and that biological fermentation is indispensable for the pharmaceutical, biopharmaceutical, biological engineering, cell engineering, and laboratory equipment industries. It is bound to usher in huge development opportunities. Based on the “venture†of the development of the biopharmaceutical industry, the holding of the Shanghai Biofermentation Exhibition 2020 will set off a new climax for the innovation and development of the biopharmaceutical industry.
It is understood that 2020 Shanghai Fermentation Exhibition, as the most anticipated annual event of the global bio-fermentation industry, will provide a competitive arena for 450 bio-fermentation industry exhibitors, 200 biotechnology and bio-pharmaceutical exhibitors with a display area of ​​40,000 square meters. Share over 40,000 professional audiences. By then, the exhibition will gather new products, new technologies, new processes and new ideas in the biopharmaceutical industry, which can effectively enhance the industry brand, visibility and economic benefits, and help the innovation and development of the biotechnology industry.
In addition, this Shanghai Bio-fermentation Exhibition is also committed to building a professional comprehensive service platform of "full industry coverage and industry-leading" that integrates "display, commerce, learning, and communication" for the bio-fermentation industry and related industries! Coupled with various supporting meetings and events during the exhibition, buyer matching meetings, seminars, exhibitions, exploration tours, selection awards, etc., will create a high-precision international biological fermentation ecosystem.
Conclusion:
At present, China is moving from a big country of generic drugs to a strong country of innovative drugs. From the perspective of the development of domestic biomedicine in recent years, biopharmaceuticals are gradually becoming “superior students†in the field of innovative drugs with the characteristics of high barriers, low decline and wide application. . Therefore, how to better promote the innovative development of medicine and biopharmaceuticals has become the focus of attention of China's pharmaceutical industry. On August 26-28, 2020, the Shanghai Bio-Fermentation Exhibition held at the Shanghai New International Expo Center as the annual feast of the bio-fermentation industry will converge the industry's heroes. Under the collision of many innovative ideas, I believe that the majority of pharmaceutical companies will Get more new development ideas!
Tips:
The investment invitation for the 8th Shanghai International Bio-fermentation Exhibition in 2020 is being carried out intensively. As a large-scale trade event for the bio-fermentation industry, the 8th Shanghai International Bio-fermentation Exhibition 2020 sincerely welcomes the active participation of many companies at home and abroad. Sustainable development of the fermentation industry! Consultation conference call Wang Cheng 18516018928 or login: for more detailed consultation;
Hard turbine speed door: set energy-saving insulation and efficient wind environmental seal in a new metal industrial doors , opening speed of up to 1.5meters per second , For applications that require frequent rapid opening of the logistics channel , Insulation thickness 0.7mm aluminum door intermediate polyurethane foam , total thickness 40mm door wide 185mm per meter weight 1.63KG, Having good thermal insulation and light weight impact strength and other characteristics , wind rating of greater than 12 and theft , The door is suitable for indoor and outdoor fast-track logistics and production , The door type for enterprises save a lot of energy due to air flow generated loss than ordinary industrial sliding doors shutter doors save energy about eighty percent , Rapid opening and closing of the door so that enterprises in the rotational speed of the production and logistics of the door is greatly improved enterprise logistics and production must pass through the channel selection and its use is directly related to the efficiency of production and logistics , This product has high reliability , practicality and easy operation and quick fix for me , Drive control using a stable energy-effcient and accurate hard to guarantee fast and reliable operation of the door system the door to ensure trouble-free operation every year more than 250,000 times
Turbine Hard High Speed Door, high speed spiral doors, aluminum high speed door, Aluminum Rapid Door, Aluminum Fast Door
SHENZHEN HONGFA AUTOMATIC DOOR CO., LTD , https://www.hongfahsrud.com